BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10608165)

  • 1. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies].
    Schurz RA; Benzer W
    Wien Klin Wochenschr; 1997; 109 Suppl 2():42-5. PubMed ID: 9340923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in postmenopausal women and cardiovascular risk].
    Karam C; Bourmayan C; Desnos M; Guérot C
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):195-201. PubMed ID: 7632028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hormone replacement therapy on the cardiovascular system].
    Payer J
    Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.